Prostate cancer screening and disease management: how screening may have an unintended effect on survival and mortality-the camel's nose effect
- PMID: 17382719
- DOI: 10.1016/j.juro.2006.11.064
Prostate cancer screening and disease management: how screening may have an unintended effect on survival and mortality-the camel's nose effect
Abstract
Purpose: Evidence suggests that men diagnosed with prostate cancer live as long as or longer than those without a diagnosis. We postulate that a reason for this paradox is increased preventive and therapeutic health care interventions following a prostate cancer diagnosis. We explored this phenomenon in patients surgically treated for prostate cancer.
Materials and methods: We examined the records of patients who underwent radical prostatectomy at Audie L. Murphy Veterans Hospital between 2001 and 2004, focusing on cancer related and comorbidity data including new diagnoses, interventions and medications.
Results: A total of 174 subjects had complete data for review. Of these men 72% had a change in medical regimen after diagnosis, 61% had a change in medication and 29% received a new medical diagnosis. Three men underwent cardiac catheterization and 1 had coronary bypass surgery.
Conclusions: These data highlight the extent of evaluation and subsequent changes in medical treatment regimens that occur after a diagnosis of prostate cancer. Such interventions would be expected to affect survival outcomes of men recently diagnosed with prostate cancer.
Comment in
-
Prostate specific antigen screening.J Urol. 2007 Apr;177(4):1225-6. doi: 10.1016/j.juro.2007.01.072. J Urol. 2007. PMID: 17382694 No abstract available.
Similar articles
-
15-year followup of a population based prostate cancer screening study.J Urol. 2009 Apr;181(4):1615-21; discussion 1621. doi: 10.1016/j.juro.2008.11.115. Epub 2009 Feb 23. J Urol. 2009. PMID: 19233435
-
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.J Urol. 2007 Apr;177(4):1307-12. doi: 10.1016/j.juro.2006.11.054. J Urol. 2007. PMID: 17382720 Clinical Trial.
-
Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.Prostate Cancer Prostatic Dis. 2008;11(3):280-7. doi: 10.1038/sj.pcan.4501015. Epub 2007 Sep 25. Prostate Cancer Prostatic Dis. 2008. PMID: 17893700
-
Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.Eur Urol. 2007 Feb;51(2):366-74; discussion 374. doi: 10.1016/j.eururo.2006.07.052. Epub 2006 Aug 15. Eur Urol. 2007. PMID: 16930812 Review.
-
Prostate cancer update: 2006.Curr Opin Oncol. 2007 May;19(3):229-33. doi: 10.1097/CCO.0b013e3280ad43bd. Curr Opin Oncol. 2007. PMID: 17414641 Review.
Cited by
-
[Uro-oncology--update 2009].Urologe A. 2009 Sep;48(9):1056-8. doi: 10.1007/s00120-009-2083-4. Urologe A. 2009. PMID: 19705096 Review. German. No abstract available.
-
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.Can J Urol. 2008 Feb;15(1):3866-71. Can J Urol. 2008. PMID: 18304396 Free PMC article.
-
Evolution of robotic surgery in the treatment of localized prostate cancer.Curr Treat Options Oncol. 2007 Jun;8(3):197-210. doi: 10.1007/s11864-007-0028-y. Curr Treat Options Oncol. 2007. PMID: 17721745 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical